ASPIRO RESEARCH AND DEVELOPMENT LLP
Company number OC373197 · Monitor this company
The annual accounts for this company are overdue.
The confirmation statement for this company is overdue.
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
What it does
The principal activity of the LLP in the year under review was that of providing funding for research and development work within the pharmaceutical industry.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Limited Liability Partnership
- Incorporated
- 2012-03-08
- Employees
- 0 (2023 accounts)
- Registered office
- 4385, OC373197 - COMPANIES HOUSE DEFAULT ADDRESS, Cardiff, CF14 8LH
- Postcode
- CF14 8LH
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2024-04-05
- Next due by
- 2026-01-05 Overdue
- Financial year end
- 5 April
Confirmation statement
- Last statement dated
- 2025-03-26
- Next due by
- 2026-04-09 Overdue
Officers 20 current · 1 resigned
Group structure
Controlled by QUADRATUS BIOFINANCE LIMITED — since 2016-04-06
Controlled by BAKER STREET TECHNOLOGIES LIMITED — since 2016-04-06
From persons-with-significant-control filings on the public register.
The class of 2012
21%
of the 492,231 companies incorporated in 2012 are still active today; 76% have since been dissolved.
A fact about the year, not a forecast for this company.